Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Kiyotaka Yoh, Shingo Matsumoto, Naoki Furuya, Kazumi Nishino, Shingo Miyamoto, Satoshi Oizumi, Norio Okamoto, Hidetoshi Itani, Shoichi Kuyama, Atsushi Nakamura, Koichi Nishi, Ikue Fukuda, Koji Tsuta, Yuichiro Hayashi, Noriko Motoi, Genichiro Ishii, Kōichi Goto